NCT02890745View on ClinicalTrials.gov

The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

January 22, 2020

Study Completion Date

January 22, 2020

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Empagliflozin

DRUG

Placebo

Trial Locations (1)

2900

Center for Diabetes Research, Gentofte Hospital, Hellerup

All Listed Sponsors
collaborator

University Hospital, Gentofte, Copenhagen

OTHER

collaborator

University of Copenhagen

OTHER

lead

Henrik Enghusen Poulsen

OTHER

NCT02890745 - The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter